Skip to main content
. 2022 Nov 23;37(11):2216–2219. doi: 10.1038/s41433-022-02318-6

Table 2.

FBLN1 level in the TAO patients and GD patients.

Variable TAO GD
(n = 25)
P value
Active TAO
(n = 30)
Inactive TAO
(n = 25)
TAO vs. GD Active vs. Inactive
FBLN1 level, pg/ml 1885.42 ± 154.82 346.37 ± 112.60 129.70 ± 11.25 <0.01 <0.01

GD Grave’s disease patients without ophthalmopathy, FBLN1 Fibulin-1, P compared by Mann–Whitney test. Significant at p  < 0.05.